US FDA approves Pfizer's blood cancer therapy
Go back to US FDA approves Pfizer's blood cancer therapy| Pfizer Inc. (NYSE: PFE) | Delayed: 27.65 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.65 | 52 Week High | $37.39 | |||
| Open | $27.65 | 52 Week Low | $28.25 | |||
| Day High | $27.65 | P/E | 16.76 | |||
| Day Low | $27.65 | EPS | $1.65 | |||
| Volume | 66,835 | |||||
